Master Program in Physiotherapy and Functioning, Federal University of Ceara, Fortaleza, Ceara, Brazil, Rua Coronel Nunes Melo, 1127, Rodolfo Teófilo, Campus Porangabussu, ZIP Code:60.430-275.
Graduate Program in Cardiovascular Sciences, Federal University of Ceara, Fortaleza, CE, Brazil, Rua Papi Júnior, 1232, sala 209, Rodolfo Teófilo, ZIP Code: 60430-235.
Heart Lung. 2024 Sep-Oct;67:183-190. doi: 10.1016/j.hrtlng.2024.05.010. Epub 2024 Jun 6.
Obstructive sleep apnoea (OSA) is a disabling health condition, and there is no disease-specific patient-reported outcome instrument to assess individuals with OSA.
To evaluate the psychometric properties of the Brazilian version of the World Health Organization Disability Assessment Schedule (WHODAS 2.0) in individuals with OSA.
One hundred individuals with OSA responded to the WHODAS 2.0 version of 36 items, the Epworth Sleepiness Scale (ESS), the Pittsburgh Sleep Quality Index (PSQI), and the 12-item health survey (SF-12). Internal consistency, convergent and discriminative validity, and responsiveness to continuous positive airway pressure (CPAP) were the psychometric properties tested.
Cronbach's α values indicate good internal consistency (0.91 - 0.73), except for the self-care domain (α = 0.52). Convergent validity indicated an excellent correlation (r = -0.80) between the domains of functioning and quality of life. Discriminative validity showed no association between OSA severity and functioning (p = 0.90). The responsiveness to CPAP treatment showed a large effect size (r = 0.82; p < 0.05) CONCLUSIONS: The WHODAS 2.0 instrument is valid, reliable, and responsive for assessing individuals with OSA.
阻塞性睡眠呼吸暂停(OSA)是一种使人丧失能力的健康状况,目前还没有专门针对 OSA 的患者报告结局工具来评估患者。
评估世界卫生组织残疾评定量表(WHODAS 2.0)巴西版本在 OSA 患者中的心理测量特性。
100 名 OSA 患者对 WHODAS 2.0 版本的 36 个项目、Epworth 嗜睡量表(ESS)、匹兹堡睡眠质量指数(PSQI)和 12 项健康调查(SF-12)进行了应答。测试了心理测量特性,包括内部一致性、收敛和判别有效性以及对持续气道正压通气(CPAP)的反应性。
Cronbach's α 值表明具有良好的内部一致性(0.91-0.73),除了自我护理领域(α=0.52)。收敛有效性表明功能和生活质量领域之间存在极好的相关性(r=-0.80)。判别有效性表明 OSA 严重程度与功能之间没有关联(p=0.90)。CPAP 治疗的反应性显示出较大的效应量(r=0.82;p<0.05)。
WHODAS 2.0 工具在评估 OSA 患者方面具有有效性、可靠性和反应性。